These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 8174958)

  • 21. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review.
    Fraser AG; Orchard TR; Jewell DP
    Gut; 2002 Apr; 50(4):485-9. PubMed ID: 11889067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early Assessment of Thiopurine Metabolites Identifies Patients at Risk of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease.
    Wong DR; Coenen MJ; Vermeulen SH; Derijks LJ; van Marrewijk CJ; Klungel OH; Scheffer H; Franke B; Guchelaar HJ; de Jong DJ; Engels LG; Verbeek AL; Hooymans PM;
    J Crohns Colitis; 2017 Feb; 11(2):175-184. PubMed ID: 27402913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Azathioprine in the treatment of children with inflammatory bowel disease.
    Verhave M; Winter HS; Grand RJ
    J Pediatr; 1990 Nov; 117(5):809-14. PubMed ID: 2231216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study.
    Gisbert JP; Luna M; Maté J; González-Guijarro L; Cara C; Pajares JM
    Hepatogastroenterology; 2006; 53(69):399-404. PubMed ID: 16795981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis.
    Hibi T; Naganuma M; Kitahora T; Kinjyo F; Shimoyama T
    J Gastroenterol; 2003; 38(8):740-6. PubMed ID: 14505127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 6-methylmercaptopurine-induced leukocytopenia during thiopurine therapy in inflammatory bowel disease patients.
    Meijer B; Kreijne JE; van Moorsel SAW; Derijks LJJ; Bouma G; Mulder CJJ; Wong DR; van der Woude CJ; van Bodegraven AA; de Boer NKH
    J Gastroenterol Hepatol; 2017 Jun; 32(6):1183-1190. PubMed ID: 27859568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
    Fangbin Z; Xiang G; Minhu C; Liang D; Feng X; Min H; Pinjin H
    Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse effects of azathioprine in the treatment of inflammatory bowel disease.
    Martínez F; Nos P; Pastor M; Garrigues V; Ponce J
    Rev Esp Enferm Dig; 2001 Dec; 93(12):769-78. PubMed ID: 11995359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Azathioprine-induced bone marrow toxicity in four dogs.
    Rinkardt NE; Kruth SA
    Can Vet J; 1996 Oct; 37(10):612-3. PubMed ID: 8896876
    [No Abstract]   [Full Text] [Related]  

  • 31. Myelotoxicity of gold.
    Kay AG
    Br Med J; 1976 May; 1(6020):1266-8. PubMed ID: 817772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatal myelotoxicity after azathioprine treatment.
    Slanar O; Chalupná P; Novotný A; Bortlík M; Krska Z; Lukás M
    Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):661-5. PubMed ID: 18600523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Severe thrombocytopenia and mild leucopenia associated with deferasirox therapy].
    Grandvuillemin A; Audia S; Leguy-Seguin V; Coullet V; Bonnotte B; Sgro C
    Therapie; 2009; 64(6):405-7. PubMed ID: 20180300
    [No Abstract]   [Full Text] [Related]  

  • 34. Increased danger of bone marrow damage in simultaneous azathioprine-allopurinol therapy.
    Zazgornik J; Kopsa H; Schmidt P; Pils P; Kuschan K; Deutsch E
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):96-7. PubMed ID: 7228457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thiopurine metabolite monitoring in paediatric inflammatory bowel disease.
    Ooi CY; Bohane TD; Lee D; Naidoo D; Day AS
    Aliment Pharmacol Ther; 2007 Apr; 25(8):941-7. PubMed ID: 17402998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
    Gearry RB; Barclay ML
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of azathioprine in the management of ulcerative colitis.
    Lobo AJ; Foster PN; Burke DA; Johnston D; Axon AT
    Dis Colon Rectum; 1990 May; 33(5):374-7. PubMed ID: 2328625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythroid toxicity of azathioprin. Macrocytosis and selective marrow hypoplasis.
    McGrath BP; Ibels LS; Raik E; Hargrave MJ
    Q J Med; 1975 Jan; 44(173):57-63. PubMed ID: 1098090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine.
    Vernier-Massouille G; Cosnes J; Lemann M; Marteau P; Reinisch W; Laharie D; Cadiot G; Bouhnik Y; De Vos M; Boureille A; Duclos B; Seksik P; Mary JY; Colombel JF
    Gut; 2007 Oct; 56(10):1404-9. PubMed ID: 17504943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myelotoxicity of D-penicillamine.
    Kay AG
    Ann Rheum Dis; 1979 Jun; 38(3):232-6. PubMed ID: 485580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.